ID27813A - COMPOUNDS FOR THERAPY AND DIAGNOSIS OF LUNG CANCER AND METHODS FOR USE - Google Patents

COMPOUNDS FOR THERAPY AND DIAGNOSIS OF LUNG CANCER AND METHODS FOR USE

Info

Publication number
ID27813A
ID27813A IDW20001646A ID20001646A ID27813A ID 27813 A ID27813 A ID 27813A ID W20001646 A IDW20001646 A ID W20001646A ID 20001646 A ID20001646 A ID 20001646A ID 27813 A ID27813 A ID 27813A
Authority
ID
Indonesia
Prior art keywords
diagnosis
therapy
compounds
methods
lung cancer
Prior art date
Application number
IDW20001646A
Other languages
Indonesian (id)
Inventor
Steven G Reed
Michael J Lodes
Tony N Frudakis
Raodoh Mohamath
Original Assignee
Corixa Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Corixa Corp filed Critical Corixa Corp
Publication of ID27813A publication Critical patent/ID27813A/en

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09Recombinant DNA-technology
    • C12N15/11DNA or RNA fragments; Modified forms thereof; Non-coding nucleic acids having a biological activity
    • C12N15/117Nucleic acids having immunomodulatory properties, e.g. containing CpG-motifs
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K14/00Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/46Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
    • C07K14/47Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00Drugs for disorders of the respiratory system
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00Antineoplastic agents
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12QMEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/68Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
    • C12Q1/6876Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes
    • C12Q1/6883Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for diseases caused by alterations of genetic material
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00Medicinal preparations containing peptides
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12QMEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q2600/00Oligonucleotides characterized by their use
    • C12Q2600/158Expression markers

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Genetics & Genomics (AREA)
  • Zoology (AREA)
  • General Health & Medical Sciences (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Wood Science & Technology (AREA)
  • Molecular Biology (AREA)
  • Medicinal Chemistry (AREA)
  • Biotechnology (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • General Engineering & Computer Science (AREA)
  • Biomedical Technology (AREA)
  • Physics & Mathematics (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Analytical Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Immunology (AREA)
  • Microbiology (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pulmonology (AREA)
  • Toxicology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Pathology (AREA)
  • Plant Pathology (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
IDW20001646A 1998-01-28 1999-01-20 COMPOUNDS FOR THERAPY AND DIAGNOSIS OF LUNG CANCER AND METHODS FOR USE ID27813A (en)

Applications Claiming Priority (8)

Application Number Priority Date Filing Date Title
US1502298A 1998-01-28 1998-01-28
US1502998A 1998-01-28 1998-01-28
US4083198A 1998-03-18 1998-03-18
US4082898A 1998-03-18 1998-03-18
US12219298A 1998-07-23 1998-07-23
US12219198A 1998-07-23 1998-07-23
US21924598A 1998-12-22 1998-12-22
PCT/US1999/001642 WO1999038973A2 (en) 1998-01-28 1999-01-26 Compounds for therapy and diagnosis of lung cancer and methods for their use

Publications (1)

Publication Number Publication Date
ID27813A true ID27813A (en) 2001-04-26

Family

ID=27567530

Family Applications (1)

Application Number Title Priority Date Filing Date
IDW20001646A ID27813A (en) 1998-01-28 1999-01-20 COMPOUNDS FOR THERAPY AND DIAGNOSIS OF LUNG CANCER AND METHODS FOR USE

Country Status (13)

Country Link
EP (1) EP1051489A2 (en)
JP (1) JP2002516659A (en)
KR (1) KR20010034436A (en)
CN (1) CN1292029A (en)
AR (1) AR014514A1 (en)
AU (1) AU2344399A (en)
BR (1) BR9907259A (en)
CA (1) CA2319117A1 (en)
ID (1) ID27813A (en)
IL (1) IL137417A0 (en)
NO (1) NO20003853L (en)
WO (1) WO1999038973A2 (en)
ZA (1) ZA99693B (en)

Families Citing this family (67)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6696247B2 (en) 1998-03-18 2004-02-24 Corixa Corporation Compounds and methods for therapy and diagnosis of lung cancer
US6426072B1 (en) 2000-08-02 2002-07-30 Corixa Corporation Compositions and methods for the therapy and diagnosis of lung cancer
US6821518B1 (en) 1998-03-18 2004-11-23 Corixa Corporation Compounds and methods for therapy and diagnosis of lung cancer
US6482597B1 (en) 1999-12-17 2002-11-19 Corixa Corporation Compounds and methods for therapy and diagnosis of lung cancer
US6660838B1 (en) 1998-03-18 2003-12-09 Corixa Corporation Compounds and methods for therapy and diagnosis of lung cancer
US6518256B1 (en) 1998-03-18 2003-02-11 Corixa Corporation Compounds and methods for therapy and diagnosis of lung cancer
US6737514B1 (en) 1998-12-22 2004-05-18 Corixa Corporation Compositions and methods for the therapy and diagnosis of lung cancer
US6706262B1 (en) 1998-03-18 2004-03-16 Corixa Corporation Compounds and methods for therapy and diagnosis of lung cancer
US6960570B2 (en) 1998-03-18 2005-11-01 Corixa Corporation Compositions and methods for the therapy and diagnosis of lung cancer
US6531315B1 (en) 1998-03-18 2003-03-11 Corixa Corporation Compositions and methods for the therapy and diagnosis of lung cancer
US7258860B2 (en) 1998-03-18 2007-08-21 Corixa Corporation Compositions and methods for the therapy and diagnosis of lung cancer
US6312695B1 (en) 1998-03-18 2001-11-06 Corixa Corporation Compounds and methods for therapy of lung cancer
US7579160B2 (en) 1998-03-18 2009-08-25 Corixa Corporation Methods for the detection of cervical cancer
US7049063B2 (en) 1998-03-18 2006-05-23 Corixa Corporation Methods for diagnosis of lung cancer
EP1526383A3 (en) * 1998-08-31 2005-11-16 Pfizer Products Inc. Diarylsulfonylurea binding proteins
EP0987552A3 (en) 1998-08-31 2000-06-07 Pfizer Products Inc. Diarylsulfonylurea binding proteins
AU766809B2 (en) * 1998-10-28 2003-10-23 Rigel Pharmaceuticals, Inc. Novel compositions and methods of screening for T-cell and B-cell activation modulators
US6709855B1 (en) 1998-12-18 2004-03-23 Scios, Inc. Methods for detection and use of differentially expressed genes in disease states
AU2055300A (en) * 1998-12-18 2000-07-03 Scios Inc. Methods for detection and use of differentially expressed genes in disease states
WO2000046370A1 (en) * 1999-02-04 2000-08-10 Board Of Trustees Of The University Of Illinois P37ing1 compositions and methods of use
US6544946B1 (en) 1999-02-19 2003-04-08 Zymogenetics, Inc. Inhibitors for use in hemostasis and immune function
ES2202061T3 (en) 1999-02-19 2004-04-01 Zymogenetics, Inc. INHIBITORS TO USE IN HEMOSTATIC AND IMMUNOLOGICAL FUNCTION.
US6444425B1 (en) 1999-04-02 2002-09-03 Corixa Corporation Compounds for therapy and diagnosis of lung cancer and methods for their use
NZ514818A (en) * 1999-04-02 2004-04-30 Corixa Corp Compounds and methods for therapy and diagnosis of lung cancer
US6759508B2 (en) 2000-09-01 2004-07-06 Corixa Corporation Compositions and methods for the therapy and diagnosis of lung cancer
AU4185100A (en) * 1999-04-02 2000-10-23 Corixa Corporation Compounds for therapy and diagnosis of lung cancer and methods for their use
US20030211510A1 (en) 1999-06-30 2003-11-13 Corixa Corporation Compositions and methods for the therapy and diagnosis of lung cancer
US6509448B2 (en) 1999-06-30 2003-01-21 Corixa Corporation Compositions and methods for the therapy and diagnosis of lung cancer
US6914132B1 (en) 1999-06-30 2005-07-05 Corixa Corporation Compositions and methods for the therapy and diagnosis of lung cancer
US6746846B1 (en) 1999-06-30 2004-06-08 Corixa Corporation Methods for diagnosing lung cancer
US6686447B1 (en) 1999-06-30 2004-02-03 Corixa Corporation Compositions and methods for the therapy and diagnosis of lung cancer
US6504010B1 (en) 1999-06-30 2003-01-07 Corixa Corporation Compositions and methods for the therapy and diagnosis of lung cancer
US6858204B2 (en) 1999-06-30 2005-02-22 Corxia Corporation Compositions and methods for the therapy and diagnosis of lung cancer
US6667154B1 (en) 1999-06-30 2003-12-23 Corixa Corporation Compositions and methods for the therapy and diagnosis of lung cancer
EP1196565A2 (en) 1999-06-30 2002-04-17 Corixa Corporation Compositions and methods for the therapy and diagnosis of lung cancer
US20030125245A1 (en) 1999-06-30 2003-07-03 Tongtong Wang Compositions and methods for therapy and diagnosis of lung cancer
CA2309313A1 (en) * 1999-08-05 2001-02-05 Board Of Trustees Of The University Of Arkansas Stimulation of the immune response by human dendritic cell manipulation
AU7832700A (en) * 1999-09-23 2001-04-24 Corixa Corporation Ovarian tumor antigen and methods of use therefor
CA2492070A1 (en) * 1999-12-01 2001-06-07 Kevin P. Baker Lung tumor marker pro4329 polypeptides and nucleic acids encoding the same
JP2004518401A (en) * 2000-04-14 2004-06-24 インサイト・ゲノミックス・インコーポレイテッド Molecules related to human reproduction
US20020099012A1 (en) * 2000-06-29 2002-07-25 Tongtong Wang Compositions and methods for the therapy and diagnosis of lung cancer
CA2415544A1 (en) * 2000-07-11 2002-01-17 Corixa Corporation Compositions and methods for the therapy and diagnosis of lung cancer
AU2001270638A1 (en) * 2000-07-19 2002-01-30 Bayer Aktiengesellschaft Regulation of human airway trypsin protease-like enzyme
TWI317380B (en) * 2000-08-28 2009-11-21 Teijin Ltd Airway-specific trypsin-like enzymes and method of using the same
AU2002249521B2 (en) 2001-01-16 2007-06-21 Serono Genetics Institute S.A. Discriminative nucleic acid analysis using clone sequence signatures
GB0101300D0 (en) * 2001-01-18 2001-02-28 Univ Cambridge Tech Primordial germ cell genes
US7226994B2 (en) 2001-01-18 2007-06-05 Cambridge University Technical Services Limited Cell surface expressed marker of pluripotency
AU2002302851A1 (en) 2001-06-21 2003-01-08 Isis Innovations Limited Atopy
AU2003243151A1 (en) * 2002-08-16 2004-03-03 Agensys, Inc. Nucleic acid and corresponding protein entitled 251p5g2 useful in treatment and detection of cancer
AU2007216892B2 (en) * 2002-08-16 2011-02-10 Agensys, Inc. Nucleic acids and corresponding proteins entitled 273P4B7 useful in treatment and detection of cancer
US20060094649A1 (en) * 2002-12-10 2006-05-04 Keogh Elissa A Hla-a1,-a2,-a3,-a24,-b7, and-b44 tumor associated antigen peptides and compositions
CA2589782A1 (en) * 2004-11-30 2006-06-08 Veridex Llc Lung cancer prognostics
US8765687B2 (en) 2005-10-17 2014-07-01 Sloan Kettering Institute For Cancer Research WT1 HLA class II-binding peptides and compositions and methods comprising same
EP2010209B1 (en) 2006-04-10 2016-06-15 Sloan Kettering Institute For Cancer Research Immunogenic wt-1 peptides and methods of use thereof
EP2423332A1 (en) * 2006-08-25 2012-02-29 Oncotherapy Science, Inc. Prognostic markers and therapeutic targets for lung cancer
US20110236314A1 (en) * 2008-09-12 2011-09-29 Cancer Research Initiatives Foundation Method of detection and diagnosis of oral and nasopharyngeal cancers
CN101891802B (en) * 2009-08-11 2011-11-16 武汉凯泰新生物技术有限公司 Polypeptide or derivative product for treating or preventing cancer and application thereof
CN101921313B (en) * 2010-04-07 2012-02-29 武汉凯泰新生物技术有限公司 Polypeptide for curing or preventing cancer or derivative product and application thereof
GB201104286D0 (en) * 2011-03-15 2011-04-27 Randox Lab Ltd Glutathione S-transferase omega 1 wild type specific antibody
US9644026B2 (en) * 2011-09-09 2017-05-09 Trans Genic Inc. Antibody against mutant α-actinin-4
CN104684577B (en) 2012-01-13 2018-05-08 纪念斯隆凯特林癌症中心 Immunogenicity WT-1 peptides and its application method
DK2945647T3 (en) 2013-01-15 2020-11-16 Memorial Sloan Kettering Cancer Center IMMUNOGENIC WT-1 PEPTIDES AND METHODS OF USE THEREOF
US10815273B2 (en) 2013-01-15 2020-10-27 Memorial Sloan Kettering Cancer Center Immunogenic WT-1 peptides and methods of use thereof
CN115109120A (en) * 2016-04-04 2022-09-27 英蒂分子公司 CD 8-specific capture agents, compositions and methods of use and preparation
CA3042880A1 (en) * 2016-11-16 2018-05-24 The Regents Of The University Of California Inhibitors of crispr-cas9
CN110669104B (en) * 2019-10-30 2021-11-05 上海交通大学 Group of markers derived from human peripheral blood mononuclear cells and application thereof
CN112500467B (en) * 2020-12-14 2022-05-24 上海交通大学 Bioactive peptide RRECPSDECGAGVF, and preparation method and application thereof

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5589579A (en) * 1994-07-19 1996-12-31 Cytoclonal Pharmaceutics, Inc. Gene sequence and probe for a marker of non-small cell lung carinoma
US5633161A (en) * 1995-03-29 1997-05-27 Millennium Pharmaceuticals, Inc. Murine gene fomy030 coding for tumor progression inhibitor

Also Published As

Publication number Publication date
EP1051489A2 (en) 2000-11-15
ZA99693B (en) 1999-10-21
KR20010034436A (en) 2001-04-25
AR014514A1 (en) 2001-02-28
CN1292029A (en) 2001-04-18
JP2002516659A (en) 2002-06-11
NO20003853L (en) 2000-09-27
IL137417A0 (en) 2001-07-24
NO20003853D0 (en) 2000-07-27
AU2344399A (en) 1999-08-16
WO1999038973A3 (en) 1999-12-09
WO1999038973A2 (en) 1999-08-05
CA2319117A1 (en) 1999-08-05
BR9907259A (en) 2002-01-22

Similar Documents

Publication Publication Date Title
ID27813A (en) COMPOUNDS FOR THERAPY AND DIAGNOSIS OF LUNG CANCER AND METHODS FOR USE
HUP0200760A2 (en) Compounds and methods for therapy and diagnosis of lung cancer
HK1045332A1 (en) Compounds for therapy and diagnosis of lung cancer and methods for their use
HUP0201757A3 (en) Compositoins and methods for the therapy and diagnosis of lung cancer
NO20010882L (en) Therapies for the treatment of lung diseases
PL366626A1 (en) Compositions and methods for the therapy and diagnosis of lung cancer
NO20010196D0 (en) Compositions and Methods for Therapy and Diagnosis of Prostate Cancer
NO971015D0 (en) Compounds and Methods for the Treatment of Cancer
ATE302414T1 (en) COMPOUNDS FOR IMMUNE DIAGNOSIS OF PROSTATE CANCER AND THEIR USE
HUP0104717A3 (en) Compositions and methods for therapy and diagnosis of ovarian cancer
AU2002218770A1 (en) Compositions and methods for the therapy and diagnosis of lung cancer
EP1516049A4 (en) Compositions and methods for the therapy and diagnosis of lung cancer
AU2002227184A1 (en) Methods for development and use of diagnostic and therapeutic agents
EP1129217A4 (en) Compositions and methods of disease diagnosis and therapy
ID26861A (en) JOIN THERAPY FOR TREATMENT OF DEPRESSION OF REFACTORS
NO994932D0 (en) Mixtures and Procedures for the Treatment and Diagnosis of Breast Cancer
EP1446013A4 (en) Compositions and methods for the therapy and diagnosis of lung cancer
FI965204A (en) Medical use of bromelain
AU2001259062A1 (en) Compositions and methods for the therapy and diagnosis of lung cancer
GB9811598D0 (en) Diagnosis and treatment of cancer
AU2001273149A1 (en) Compositions and methods for the therapy and diagnosis of lung cancer
AU2003230849A8 (en) Compositions and methods for the therapy and diagnosis of lung cancer
AU2001273127A1 (en) Compositions and methods for the therapy and diagnosis of lung cancer
PT1064014E (en) MEDICATION FOR THE IMPEDIMENT OR TREATMENT OF SPECIFIC PAPILOMAVIRUS TUMORS
HK1046019A1 (en) Compositions and methods for the therapy and diagnosis of lung cancer